tiprankstipranks
Novartis (GB:0QLR)
LSE:0QLR
UK Market

Novartis AG (0QLR) Financial Statements

Compare
10 Followers

Novartis AG Financial Overview

Novartis AG's market cap is currently CHF194.41B. The company's EPS TTM is CHF5.211; its P/E ratio is 18.48; and it has a dividend yield of 3.43%. Novartis AG is scheduled to report earnings on January 31, 2025, and the estimated EPS forecast is CHF1.83. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue
Gross Profit$ 34.19B$ 31.88B$ 32.24B$ 34.78B$ 34.25B
Operating Income$ 8.00B$ 9.20B$ 11.69B$ 55.83B$ 53.37B
EBITDA-$ 14.68B$ 30.91B$ 17.21B$ 9.79B
Net Income$ 14.85B$ 6.96B$ 24.02B$ 8.07B$ 81.53B
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 99.94B$ 117.45B$ 131.79B$ 127.78B$ 118.37B
Total Debt$ 20.26B$ 27.91B$ 31.02B$ 37.85B$ 29.15B
Net Debt$ 5.84B$ 27.77B$ 30.82B$ 28.22B$ 20.50B
Total Liabilities$ 53.20B$ 58.03B$ 63.97B$ 71.11B$ 62.82B
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ 13.90B$ 11.77B$ 12.79B$ 11.38B$ 12.28B
Operating Cash Flow$ 14.46B$ 14.24B$ 15.07B$ 13.65B$ 13.63B
Investing Cash Flow
Financing Cash Flow
Currency in USD

Novartis AG Earnings and Revenue History

Novartis AG Debt to Assets

Novartis AG Cash Flow

Novartis AG Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis